株探米国株
英語
エドガーで原本を確認する
0000018349false00000183492024-04-242024-04-240000018349us-gaap:CommonStockMember2024-04-242024-04-240000018349us-gaap:SeriesDPreferredStockMember2024-04-242024-04-240000018349us-gaap:SeriesEPreferredStockMember2024-04-242024-04-24

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

April 24, 2024
Date of Report
(Date of Earliest Event Reported)

Synovus Financial Corp.
(Exact Name of Registrant as Specified in its Charter)

Georgia 1-10312 58-1134883
(State of Incorporation) (Commission File Number) (IRS Employer Identification No.)

1111 Bay Avenue, Suite 500, Columbus, Georgia 31901
(Address of principal executive offices) (Zip Code)

(706) 641-6500
(Registrant’s telephone number, including area code)

________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, $1.00 Par Value
SNV
New York Stock Exchange
Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series D
SNV-PrD
New York Stock Exchange
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series E
SNV-PrE
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.07
Submission of Matters to a Vote of Security Holders.

The Company’s 2024 Annual Meeting of Shareholders was held on April 24, 2024. The following is a summary of the proposals that were submitted to the shareholders for approval and a tabulation of the votes with respect to each proposal.

Proposal 1

The following 11 nominees named in the proxy statement for the Company’s 2024 Annual Meeting of Shareholders were elected by majority vote.

Nominee Votes For Vote Against Abstentions
Stacy Apter 113,372,649 188,127 142,113
Tim Bentsen 111,125,424 2,421,756 155,709
Kevin Blair 109,794,805 3,749,062 159,022
Pedro Cherry 113,354,754 192,755 155,380
John Irby 112,366,009 1,183,641 153,239
Diana M. Murphy 109,275,530 4,282,156 145,203
Harris Pastides 112,392,373 1,158,344 152,172
John L. Stallworth 113,037,762 517,410 147,717
Barry L. Storey 110,347,006 3,193,022 162,861
Alexandra Villoch 113,011,253 547,382 144,254
Teresa White 112,333,607 1,212,591 156,691

There were 20,253,733 broker non-votes for each director on this proposal.

Proposal 2

An advisory vote on the compensation of the Company’s named executive officers as determined by the Compensation and Human Capital Committee was approved.

Votes For Votes Against Abstentions Broker Non-Votes
110,736,998 2,781,963 183,928 20,253,733

Proposal 3

The appointment of KPMG LLP as the Company’s independent auditor for the fiscal year ended December 31, 2024 was ratified.

Votes For Votes Against Abstentions Broker Non-Votes
131,442,597 2,416,083 97,942 0



Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, Synovus has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SYNOVUS FINANCIAL CORP.
Date: April 26, 2024
By: /s/ Allan E. Kamensky
Name: Allan E. Kamensky
Title: Executive Vice President and General Counsel